Unveiling the enigma: A challenging case of protein C deficiency concealed by fever and epistaxis

Iman Jauhar1, Muhammad Mubashir1, Muhammad Shehryar Wahla2

  • 1Department of Medicine, Liaquat National Hospital and Medical College, Karachi, Pakistan.

PubMed

Insights

Protein C deficiency, a rare genetic disorder, increases blood clot risk. Early diagnosis and lifelong anticoagulation are vital for managing venous thromboembolism complications in young patients.

Area of Science:

  • Genetics
  • Hematology
  • Vascular Medicine

Background:

  • Protein C deficiency is a rare inherited thrombophilia affecting 1 in 200-500 individuals.
  • Caused by mutations in the F5 gene, it leads to a hypercoagulable state and increased risk of thrombosis.
  • Clinical manifestations range from neonatal purpura fulminans to adult venous thromboembolism (VTE).

Observation:

  • A 21-year-old South Asian male presented with symptoms suggestive of deep vein thrombosis (DVT).
  • Diagnostic tests confirmed extensive DVT in the legs and a pulmonary embolism (PE).
  • The patient was diagnosed with protein C deficiency.

Findings:

  • The patient received anticoagulant therapy, thrombolysis, and an inferior vena cava filter for extensive DVT and PE.
  • Complications of protein C deficiency include DVT, PE, stroke, and ischemic colitis.
  • Diagnosis relies on immunoassays and genetic analysis, with lifelong anticoagulation often required.

Implications:

  • This case highlights the critical need for early diagnosis and management of protein C deficiency in young VTE patients.
  • Prompt treatment, including anticoagulation and potentially an IVC filter, is essential to prevent severe complications.
  • Lifelong anticoagulation therapy is crucial for managing protein C deficiency and preventing recurrent thrombotic events.

Related Concept Videos

Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
900
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
199
Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
141
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
148
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
193